366 related articles for article (PubMed ID: 24168994)
1. Effect of intravitreal injection of bevacizumab on optic nerve head leakage and retinal ganglion cell survival in a mouse model of optic nerve crush.
Rappoport D; Morzaev D; Weiss S; Vieyra M; Nicholson JD; Leiba H; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8160-71. PubMed ID: 24168994
[TBL] [Abstract][Full Text] [Related]
2. Ocular Effects of Sildenafil in Naïve Mice and a Mouse Model of Optic Nerve Crush.
Zahavi A; Weiss S; Vieyra M; Nicholson JD; Muhsinoglu O; Barinfeld O; Zadok D; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1987-1995. PubMed ID: 31063183
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effects of Human Serum Albumin Nanoparticles Loaded With Brimonidine on Retinal Ganglion Cells in Optic Nerve Crush Model.
Kim KE; Jang I; Moon H; Kim YJ; Jeoung JW; Park KH; Kim H
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5641-9. PubMed ID: 26313300
[TBL] [Abstract][Full Text] [Related]
4. Methane rescues retinal ganglion cells and limits retinal mitochondrial dysfunction following optic nerve crush.
Wang R; Sun Q; Xia F; Chen Z; Wu J; Zhang Y; Xu J; Liu L
Exp Eye Res; 2017 Jun; 159():49-57. PubMed ID: 28336261
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of Epigallocatechin-3-gallate (EGCG) in optic nerve crush model in rats.
Xie J; Jiang L; Zhang T; Jin Y; Yang D; Chen F
Neurosci Lett; 2010 Jul; 479(1):26-30. PubMed ID: 20471452
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of inhibitors of Acid-Sensing ion channels (ASICs) in optic nerve crush model in rodents.
Stankowska DL; Mueller BH; Oku H; Ikeda T; Dibas A
Curr Eye Res; 2018 Jan; 43(1):84-95. PubMed ID: 29111855
[TBL] [Abstract][Full Text] [Related]
7. [Effect of VEGF-B on neuroprotection in mouse retinal ganglion cells].
Zhang SH; Yi Q
Zhonghua Yan Ke Za Zhi; 2009 Jan; 45(1):38-42. PubMed ID: 19484929
[TBL] [Abstract][Full Text] [Related]
8. Celastrol supports survival of retinal ganglion cells injured by optic nerve crush.
Kyung H; Kwong JM; Bekerman V; Gu L; Yadegari D; Caprioli J; Piri N
Brain Res; 2015 Jun; 1609():21-30. PubMed ID: 25813825
[TBL] [Abstract][Full Text] [Related]
9. Monitoring retinal morphologic and functional changes in mice following optic nerve crush.
Liu Y; McDowell CM; Zhang Z; Tebow HE; Wordinger RJ; Clark AF
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3766-74. PubMed ID: 24854856
[TBL] [Abstract][Full Text] [Related]
10. BDNF enhances retinal ganglion cell survival in cats with optic nerve damage.
Chen H; Weber AJ
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):966-74. PubMed ID: 11274073
[TBL] [Abstract][Full Text] [Related]
11. Differential protection of injured retinal ganglion cell dendrites by brimonidine.
Lindsey JD; Duong-Polk KX; Hammond D; Chindasub P; Leung CK; Weinreb RN
Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1789-804. PubMed ID: 25634981
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor-4 knockout mice are more resistant to optic nerve crush damage than wild-type mice.
Morzaev D; Nicholson JD; Caspi T; Weiss S; Hochhauser E; Goldenberg-Cohen N
Clin Exp Ophthalmol; 2015; 43(7):655-65. PubMed ID: 25752496
[TBL] [Abstract][Full Text] [Related]
13. Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells.
Levkovitch-Verbin H; Quigley HA; Kerrigan-Baumrind LA; D'Anna SA; Kerrigan D; Pease ME
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):975-82. PubMed ID: 11274074
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of intravitreal injection of bevacizumab on nerve growth factor.
Jee D; Lee WK
Curr Eye Res; 2012 May; 37(5):408-15. PubMed ID: 22040304
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of tempol on retinal ganglion cells in a partial optic nerve crush rat model with and without iron load.
Thaler S; Fiedorowicz M; Rejdak R; Choragiewicz TJ; Sulejczak D; Stopa P; Zarnowski T; Zrenner E; Grieb P; Schuettauf F
Exp Eye Res; 2010 Feb; 90(2):254-60. PubMed ID: 19883642
[TBL] [Abstract][Full Text] [Related]
16. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection.
Levkovitch-Verbin H; Harris-Cerruti C; Groner Y; Wheeler LA; Schwartz M; Yoles E
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4169-74. PubMed ID: 11095611
[TBL] [Abstract][Full Text] [Related]
17. Tumor Necrosis Factor Inhibition in the Acute Management of Traumatic Optic Neuropathy.
Tse BC; Dvoriantchikova G; Tao W; Gallo RA; Lee JY; Pappas S; Brambilla R; Ivanov D; Tse DT; Pelaez D
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2905-2912. PubMed ID: 30025145
[TBL] [Abstract][Full Text] [Related]
18. Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury.
Schmitt HM; Schlamp CL; Nickells RW
J Ocul Pharmacol Ther; 2018 Apr; 34(3):260-273. PubMed ID: 29211617
[TBL] [Abstract][Full Text] [Related]
19. α-Crystallin protects RGC survival and inhibits microglial activation after optic nerve crush.
Wu N; Yu J; Chen S; Xu J; Ying X; Ye M; Li Y; Wang Y
Life Sci; 2014 Jan; 94(1):17-23. PubMed ID: 24220677
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic Retinal Ganglion Cell Death After Optic Nerve Transection or Crush in Mice: Delayed RGC Loss With BDNF or a Caspase 3 Inhibitor.
Sánchez-Migallón MC; Valiente-Soriano FJ; Nadal-Nicolás FM; Vidal-Sanz M; Agudo-Barriuso M
Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):81-93. PubMed ID: 26780312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
